Cidara Therapeutics
CDTX
CDTX
52 hedge funds and large institutions have $22.7M invested in Cidara Therapeutics in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 12 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
0.12% less ownership
Funds ownership: 1.46% → 1.33% (-0.12%)
24% less capital invested
Capital invested by funds: $29.7M → $22.7M (-$6.99M)
Holders
52
Holding in Top 10
1
Calls
$78K
Puts
$1K
Top Buyers
| 1 | +$129K | |
| 2 | +$80.4K | |
| 3 | +$73.7K | |
| 4 |
PFCS
Pale Fire Capital SE
Prague,
Czech Republic
|
+$51.2K |
| 5 |
Renaissance Technologies
New York
|
+$47.2K |
Top Sellers
| 1 | -$1.34M | |
| 2 | -$240K | |
| 3 | -$232K | |
| 4 |
Two Sigma Investments
New York
|
-$157K |
| 5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$154K |